V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000218 | 230000130 | 1.54 | 76.7 | Adjuvant (A) | 2016-11-22 | 2016-11-23 | ESPAC-4 TRIAL | 02 | N | 230026771 | OXALIPLATIN + MDG |
| 230000219 | 230000131 | 1.79 | 0 | Palliative (P) | 2013-02-21 | 2013-03-14 | Olaparib | 2 | N | 230026784 | FLUOROURACIL |
| 230000220 | 230000132 | null | null | Adjuvant (A) | 2016-01-09 | 2016-01-16 | Fluorouracil + Folinic Acid (Mayo) | null | null | 230026823 | PACLITAXEL |
| 230000221 | 230001104 | 1.7 | 117.9 | Neo-adjuvant (N) | 2013-10-06 | 2013-10-13 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 230026832 | ARISTOTLE TRIAL |
| 230000222 | 230001104 | 1.61 | 69 | Disease modification (D) | null | 2014-11-22 | Capecitabine + Mitomycin | null | N | 230026832 | CAPECITABINE |
| 230000223 | 230001104 | 1.81 | 73.2 | null | 2014-03-19 | 2014-04-04 | Fluorouracil + Folinic Acid Weekly | N | N | 230026832 | OXALIPLATIN + MDG |
| 230000224 | 230001104 | 1.7 | 60 | Palliative (P) | 2018-03-31 | 2018-04-05 | Carboplatin + Etoposide iv&po | 2 | N | 230026832 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230000225 | 230000133 | 1.66 | 89.4 | Not known (9) | 2017-10-18 | 2017-10-24 | CAPECITABINE + RT | N | N | 230026989 | OXALIPLATIN + MDG |
| 230000226 | 230000134 | 1.6 | 69 | Curative (C) | 2016-09-25 | 2016-10-07 | Capecitabine + Oxaliplatin 21day | N | 2 | 230027105 | OXALIPLATIN + MDG |
| 230000227 | 230000134 | 1.66 | 69.3 | Palliative (P) | 2017-05-05 | 2017-05-24 | CAPECITABINE + OXALIPLATIN | 2 | null | 230027105 | CAPECITABINE + OXALIPLATIN |
| 230000228 | 230000135 | 1.6 | 57.8 | Not known (9) | 2016-01-31 | 2016-02-28 | Bevacizumab + Cape + Oxali 21day | 02 | N | 230027265 | CAPECITABINE |
| 230000229 | 230000136 | 1.75 | 91 | Curative (C) | 2014-06-02 | 2014-06-17 | Docetaxel 75mg/m2 (21 day) | 02 | Y | 230027293 | FLUOROURACIL |
| 230000230 | 230000136 | 1.65 | 69 | Neo-adjuvant (N) | 2013-11-30 | 2013-12-01 | Irinotecan + Modified De Gramont | 02 | Y | 230027293 | CAPECITABINE |
| 230000231 | 230001468 | 1.71 | 65 | Adjuvant (A) | 2016-09-20 | 2016-10-03 | FEC 60 or 75 | N | N | 230027511 | CAPECITABINE |
| 230000232 | 230000137 | 1.56 | 56.6 | Adjuvant (A) | 2015-12-28 | 2016-01-13 | FLUOROURACIL + MITOMYCIN + RT | N | N | 230027513 | FLUOROURACIL + MITOMYCIN + RT |
| 230000233 | 230000138 | null | 77.5 | Adjuvant (A) | 2018-02-28 | 2018-03-02 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | N | 230027570 | CAPECITABINE + OXALIPLATIN |
| 230000234 | 230000139 | 1.61 | 97.1 | Adjuvant (A) | 2018-03-13 | 2018-03-13 | CAPECITABINE + OXALIPLATIN | 2 | N | 230027610 | MEDROXYPROGESTERONE |
| 230000235 | 230001107 | 1.78 | 79.6 | Adjuvant (A) | 2016-03-22 | 2017-08-09 | Capecitabine | N | N | 230027688 | CAPECITABINE |
| 230000236 | 230000140 | 1.6 | 0 | Palliative (P) | 2015-12-22 | 2015-12-22 | Capecitabine + Oxaliplatin 21day | 02 | N | 230027736 | FLUOROURACIL |
| 230000237 | 230000140 | null | 49.2 | Curative (C) | 2017-12-15 | 2017-12-16 | Oxaliplatin + Modified de Gramont | N | N | 230027736 | CAPECITABINE + OXALIPLATIN |
| 230000238 | 230000141 | null | 57.5 | null | 2017-02-13 | 2017-02-13 | CHOP R - 21 days | N | null | 230027779 | CAPECITABINE |
| 230000239 | 230001109 | 1.55 | 87.6 | Adjuvant (A) | 2012-02-27 | 2013-03-14 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 230027869 | IRINOTECAN + MDG |
| 230000240 | 230001109 | 1.72 | 73.9 | Adjuvant (A) | 2013-08-16 | 2013-08-16 | Oxaliplatin + Modified de Gramont | N | N | 230027869 | CAPECITABINE + OXALIPLATIN |
| 230000242 | 230001701 | 1.58 | null | Palliative (P) | null | 2015-09-26 | Capecitabine 35days + RT | N | N | 230027998 | CAPECITABINE |
| 230000243 | 230000142 | 1.77 | 94 | Palliative (P) | 2016-10-09 | 2016-10-24 | GEMCITABINE | N | N | 230028000 | CAPECITABINE + OXALIPLATIN |
| 230000244 | 230000143 | 1.92 | 93 | Adjuvant (A) | 2015-05-13 | 2015-05-19 | Carboplatin + Pemetrexed | 02 | null | 230028076 | CAPECITABINE + OXALIPLATIN |
| 230000245 | 230000144 | 1.73 | 83.3 | Adjuvant (A) | 2013-10-26 | 2013-11-20 | Cyclophosphamide+Doce+Tras Main | N | N | 230028266 | CAPECITABINE + OXALIPLATIN |
| 230000246 | 230000144 | 1.64 | 58.5 | Palliative (P) | 2013-05-13 | 2013-05-13 | Capecitabine | 2 | N | 230028266 | BCG |
| 230000247 | 230000144 | 1.59 | 0 | Palliative (P) | 2013-07-30 | 2013-08-28 | Folfirinox | N | N | 230028266 | CAPECITABINE + OXALIPLATIN |
| 230000248 | 230000144 | 1.52 | 101.8 | Palliative (P) | 2016-12-05 | 2016-12-05 | Oxaliplatin + Modified de Gramont | N | N | 230028266 | CAPECITABINE + OXALIPLATIN |
| 230000249 | 230000144 | 1.54 | 48.2 | Neo-adjuvant (N) | 2014-10-01 | 2014-10-07 | Azacitidine | N | N | 230028266 | CAPECITABINE + IRINOTECAN |
| 230000250 | 230000144 | null | 107 | Adjuvant (A) | 2013-06-11 | 2013-06-11 | CAPECITABINE + OXALIPLATIN | 02 | N | 230028266 | CAPECITABINE + OXALIPLATIN |
| 230000251 | 230000144 | 1.68 | 68.3 | Palliative (P) | 2018-01-26 | 2018-02-04 | Capecitabine + Oxaliplatin 21day | N | N | 230028266 | CAPECITABINE + RT |
| 230000252 | 230000145 | null | null | Neo-adjuvant (N) | 2016-02-05 | 2016-02-09 | FLUOROURACIL + IRINOTECAN | Y | N | 230000010 | OXALIPLATIN + MDG |
| 230000253 | 230000146 | 1.53 | null | Adjuvant (A) | 2015-01-29 | 2015-01-30 | Capecitabine | 02 | N | 230000016 | IRINOTECAN + MDG |
| 230000254 | 230000147 | null | null | Neo-adjuvant (N) | 2016-04-25 | 2016-04-27 | Cisplatin + Docetaxel | N | null | 230000021 | FLUOROURACIL |
| 230000255 | 230000148 | 1.71 | 84 | null | 2014-02-07 | 2014-02-22 | Carboplatin + Pemetrexed | 02 | N | 230000026 | CVP R |
| 230000256 | 230000149 | 1.72 | 62 | Neo-adjuvant (N) | 2015-03-20 | 2015-04-02 | CAPECITABINE + OXALIPLATIN | 2 | N | 230000028 | CAPECITABINE |
| 230000257 | 230000149 | 1.53 | 79.5 | null | 2013-12-05 | 2013-12-11 | CHOP R - 21 days | N | N | 230000028 | FLUOROURACIL |
| 230000258 | 230000149 | 1.58 | 81 | Adjuvant (A) | 2017-06-14 | 2017-07-11 | Sorafenib | N | null | 230000028 | CAPECITABINE + RT |
| 230000259 | 230000149 | null | null | Palliative (P) | 2015-05-29 | 2015-06-20 | Oxaliplatin + Modified de Gramont | N | null | 230000028 | SCOT TRIAL |
| 230000260 | 230000150 | 1.59 | 105 | null | 2015-01-26 | 2015-01-26 | Capecitabine + Mitomycin | null | null | 230000131 | CAPECITABINE + RT |
| 230000261 | 230000151 | 1.63 | 64 | Curative (C) | 2016-08-18 | 2016-08-31 | TEMOZOLOMIDE | N | N | 230000139 | CAPECITABINE |
| 230000262 | 230000151 | 1.65 | 58.5 | Palliative (P) | 2015-09-24 | 2015-10-28 | EC | N | N | 230000139 | CAPECITABINE + OXALIPLATIN |
| 230000263 | 230000152 | 1.83 | null | Adjuvant (A) | null | 2015-03-03 | CAPECITABINE + OXALIPLATIN | Y | N | 230000165 | CAPECITABINE + OXALIPLATIN |
| 230000264 | 230000153 | 1.64 | 59 | Curative (C) | 2016-06-25 | 2016-07-21 | Sorafenib | 02 | N | 230000178 | CAPECITABINE |
| 230000265 | 230000153 | 1.57 | 50.8 | Adjuvant (A) | 2013-12-28 | 2014-01-02 | VANDETANIB | N | N | 230000178 | CAPECITABINE |
| 230000266 | 230000153 | 1.68 | 60.55 | Adjuvant (A) | 2014-04-21 | 2014-04-25 | AFATINIB | N | N | 230000178 | CAPECITABINE |
| 230000267 | 230000154 | 1.77 | 65.7 | Palliative (P) | 2016-05-27 | 2016-05-27 | CAPECITABINE + RT | 02 | N | 230000342 | CAPECITABINE + OXALIPLATIN |
| 230000268 | 230000155 | 1.7 | 58.1 | Palliative (P) | 2018-08-20 | 2018-08-27 | CARBOPLATIN + ETOPOSIDE | N | N | 230000370 | CAPECITABINE + OXALIPLATIN |